Seoul, South Korea

Dong Ho Woo


Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Dong Ho Woo

Introduction

Dong Ho Woo is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, holding 2 patents that focus on innovative compounds and methods for medical applications.

Latest Patents

His latest patents include a phenoxypropanol derivative and a pharmaceutical composition that utilizes this derivative. This invention relates to a novel phenoxypropanol derivative, represented by the structure of Chemical Formula I, which can be used for blocking T-type calcium channels and/or TREK channels. This has potential applications in preventing and treating diseases associated with these channels. Another significant patent involves a method for screening a glutamate release inhibitor in astrocytes. This invention investigates the two modes of glutamate release and provides techniques for neuron protection and acceleration of neurotransmission by controlling glutamate release.

Career Highlights

Dong Ho Woo is affiliated with the Korea Institute of Science and Technology, where he conducts his research and development activities. His work is pivotal in advancing pharmaceutical sciences and improving therapeutic strategies.

Collaborations

He collaborates with esteemed colleagues such as ChangJoon Justin Lee and Soo Jin Oh, contributing to a dynamic research environment that fosters innovation.

Conclusion

Dong Ho Woo's contributions to the field of pharmaceuticals through his patents and research at the Korea Institute of Science and Technology highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…